Industrial Market Research Reports

MBD MARKET RESEARCH REPORTS

  

Search the MBD site:

MARKET RESEARCH REPORTS:


Building Products

Building Services

Business Services

Catering & Tourism

Chemicals

Construction

Distribution

Engineering

Environmental

European Construction

FITs Market

Health & Medical

ICT & Electronics

Materials

Packaging

Process Industries

Public Expenditure

Publishing & Media

Security

Transport

Utilities

 

HOME > MARKET RESEARCH REPORTS > UK Pharmceutical Products Market Research Report

 

Market Research

UK Pharmceutical Products Market Research Report

Published: October 2005

 

The UK pharmaceutical market and industry is analysed in this report, covering end user markets for prescription medicines and over the counter products as well as the apparent UK markets for basic pharmaceuticals and pharmaceutical preparations. Market trends are fully detailed, including appraisal of demographic factors, NHS expenditure trends, generic drug activity and outsourcing and the impact of PPRS.

The report contains five year historical data, current market conditions and influences, together with a five year sector forecast by MBD analysts. The data is clearly presented and illustrated.

 

Prices:

A single report is priced at £550 ($860)

The benefits of subscribing to the annual service are:
- You always have in hand a report that has considered the latest market and economic conditions
- The data is integrated with past analysis, so all the facts are in hand in one document
- You are entitled to use the faxback service, whereby for no extra charge you can discuss the report information and analysis with the consultant.

MBD now offer even more flexible packages:

- If you are interested in more than one title, we have generous discount schemes to reward your volume purchasing. Please contact our sales team who will be happy to discuss the discount that applies to the number of reports you want.
- Alternatively, you can now download reports immediately via the MBD e-commerce facility. That site allows access to annual subscription, full reports, or even individual chapters.

 

Contents:

Table of Contents

1. EXECUTIVE SUMMARY

2. INTRODUCTION
2.1 Definitions
2.2 Abbreviations
2.3 Market Positioning
2.4 UK Economy
2.5 Market Factors

3. MARKET SIZE AND TRENDS
3.1 Chapter Summary
3.2 Market Size
3.3 Market Segmentation
3.3.1 Prescription Medicines
3.3.2 OTC Medicines
3.4 Market Trends
3.4.1 Demographics
3.4.2 Expenditure
3.4.3 Distribution
3.4.4 Generics
3.4.5 Outsourcing
3.4.6 Parallel Trade
3.4.7 Herbal Medicines

4. SUPPLY SOURCES
4.1 Chapter Summary
4.2 Production
4.2.1 Overview
4.2.2 Segmentation
4.3 Imports
4.3.1 Overview
4.3.2 Segmentation
4.4 Exports
4.4.1 Overview
4.4.2 Segmentation
4.5 Trade Surplus/Deficit

5. INDUSTRY STRUCTURE
5.1 Chapter Summary
5.2 Industry Development
5.3 Structure by Employment
5.4 Structure by Turnover
5.5 Company Profiles
5.5.1 AstraZeneca
5.5.2 Bristol-Myers Squibb Pharmaceuticals
5.5.3 Celltech Group
5.5.4 Eli Lilly & Co
5.5.5 GE Healthcare
5.5.6 GlaxoSmithKline
5.5.7 Johnson & Johnson Medical
5.5.8 Merck Sharp & Dohme
5.5.9 Novartis UK
5.5.10 Pfizer
5.5.11 Pharmacia
5.5.12 Roche Products
5.5.13 Shire Pharmaceuticals Group
5.5.14 Unichem
5.5.15 3M Health Care

6. FORECAST
6.1 Chapter Summary
6.2 Market Size
6.3 Market Segmentation
6.4 Industry

7. FURTHER SOURCES & CONTACTS
7.1 Trade Associations
7.2 Trade Magazines
7.3 Trade Exhibitions

List of Tables

UK Apparent Consumption for Pharmaceutical Products, 2001-2005
2: UK Market for Pharmaceutical Products, 2001-2005
3: Segmentation of UK Apparent Consumption of Pharmaceutical Products, 2001-2005
4: Segmentation of the UK Market for Pharmaceutical Products, 2001-2005
5: Segmentation of the UK Market for Pharmaceutical Products, 2001-2005
6: Number of Prescription Items Dispensed in the UK Market, by Country, 2000-2004
7: Prescription Items Dispensed in England & Scotland, by Disease, 2004
8: UK Market for OTC Pharmaceutical Products and Top Branded Sellers, by Therapeutic Category, 2005
9: UK Population, by Age Group, 1981-2021
10: NHS Expenditure on Medicines in the UK, 2000-2004
11: NHS Pharmacies in England and Wales, 2000-2004
12: UK Production of Pharmaceutical Products, 2001-2005
13: Segmentation of the UK Production of Pharmaceutical Products, by Type, 2001-2005
14: UK Imports of Pharmaceutical Products, 2001-2005
15: Segmentation of UK Imports of Pharmaceutical Products, by Type, 2001-2005
16: UK Exports of Pharmaceutical Products, 2001-2005
17: Segmentation of UK Exports of Pharmaceutical Products, by Type, 2001-2005
18: Analysis of the Changes in the Structure of the Basic Pharmaceuticals Manufacturing Industry, 2001-2005
19: Analysis of the Changes in the Structure of the Pharmaceutical Preparations Manufacturing Industry, 2001-2005
20: Analysis of the Employment Structure of the Basic Pharmaceuticals Manufacturing Industry, 2004 and 2005
21: Analysis of the Employment Structure of the Pharmaceutical Preparations
Manufacturing Industry, 2004 and 2005
22: Analysis of the Financial Structure of the Basic Pharmaceuticals Manufacturing Sector, 2004 and 2005
23: Analysis of the Financial Structure of the Pharmaceutical Preparations Manufacturing Sector, 2004 and 2005
24: Financial Analysis of AstraZeneca, 2000-2004
25: Key Financial Ratios for AstraZeneca, 2000-2004
26: Financial Analysis of Bristol-Myers Squibb Pharmaceuticals, 2000-2004
27: Key Financial Ratios for Bristol-Myers Squibb Pharmaceuticals, 2000-2004
28: Financial Analysis of Celltech Group, 1999-2003
29: Key Financial Ratios for Celltech Group, 1999-2003
30: Financial Analysis of Eli Lilly & Company, 1999-2003
31: Key Financial Ratios for Eli Lilly & Company, 1999-2003
32: Financial Analysis of GE Healthcare, 1999-2003
33: Key Financial Ratios for GE Healthcare, 1999-2003
34: Financial Analysis of GlaxoSmithKline, 2000-2004
35: Key Financial Ratios for GlaxoSmithKline, 2000-2004
36: Financial Analysis of Johnson & Johnson Medical, 1999-2003
37: Key Financial Ratios for Johnson & Johnson Medical, 1999-2003
38: Financial Analysis of Merck Sharp & Dohme, 1999-2003
39: Key Financial Ratios for Merck Sharp & Dome, 1999-2003
40: Financial Analysis of Novartis UK, 2000-2004
41: Key Financial Ratios for Novartis UK, 2000-2004
42: Financial Analysis of Pfizer, 2000-2004
43: Key Financial Ratios for Pfizer, 2000-2004
44: Financial Analysis of Pharmacia, 2000-2004
45: Key Financial Ratios for Pharmacia, 2000-2004
46: Financial Analysis of Roche Products, 2000-2004
47: Key Financial Ratios for Roche Products, 2000-2004
48: Financial Analysis of Shire Pharmaceuticals Group, 2000-2004
49: Key Financial Ratios for Shire Pharmaceuticals Group, 2000-2004
50: Financial Analysis of Unichem, 2000-2004
51: Key Financial Ratios for Unichem, 2000-2004
52: Financial Analysis of 3M Health Care, 2000-2004
53: Key Financial Ratios for 3M Health Care, 2000-2004
54: Forecast UK Apparent Consumption for Pharmaceutical Products, 2006-2010
55: Forecast UK Market for Pharmaceutical Products, 2006-2010
56: Forecast Segmentation of UK Apparent Consumption of Pharmaceutical Products
2006-2010
57: Forecast Segmentation of the UK Market for Pharmaceutical Products, 2006-2010

 

Ordering:

All reports can be order online using the MBD e-commerce facility or by calling our dedicated sales team on 0161 233 7094. Alternatively print our order form to order by post or fax.

 

Further information :

To discuss the contects of this report further please contact the MBD Sales Team on 0161 233 7094 or email your questions.

Click here to print this page.

 
Forecast

 

MCi, Barnett House, 53 Fountain Street, Manchester, M2 2AN
   
Tel: 0161 233 7092
Fax: 0161 233 7093
Trends MBD, UK